FDA Issues New Draft Guidances for Generic Trials

By Sam | July 20, 2018

The FDA on Friday published 26 new product-specific draft guidances for generic drug trials and 17 revisions, saying it hopes to broaden access and help cheaper drugs get to market more quickly — including opioids formulated to deter abuse.
Source: Drug Industry Daily

Posted in Drug Industry Daily